3-IODO-6,6-DIMETHYL-4,5,6,7-TETRAHYDRO-1H-INDAZOLE, 95.0%, 100mg

6-Aminopyridine-3-carbothioamide, 95+%, 100mg

5'-Bromo-2'-hydroxypropiophenone, 95.0%, 5g

(R)-4-Phenyl-2-(quinolin-8-yl)-4,5-dihydrooxazole, 98%, 1g

4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-amine, 98%, 1g

tert-Butyl (2-chloro-5-(trifluoromethyl)pyridin-3-yl)carbamate, 97%, 250mg

1-Boc-4-(4-Cyanobenzyl)piperazine, 95.0%, 1g

N-([1,1':3',1''-terphenyl]-5'-yl)-9,9-dimethyl-9H-fluoren-2-amine, 97%, 100mg

SULFAQUINOXALINE, 96%, 250mg

NAM [=N-(9-Acridinyl)maleimide] [for HPLC Labeling]>98.0%(HPLC)100mg

4-(Piperidin-3-ylthio)pyridine dihydrochloride, 97%, 1g

1-Heptanol, min. 99%, for synthesis, 500 ml, glass packaging

4-METHYL-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-BENZYL ESTER, 95.0%, 1g